Showing results (91-100 of 114) with videos related to
Sort By:
Pageof 12
The Journal of Infectious Diseases|August 21, 2012
Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndromeYulan Sun, Cong Jin, Faxian Zhan, et al.Virology Journal|January 19, 2010
Genetic analysis of chikungunya viruses imported to mainland China in 2008Kui Zheng, Jiandong Li, Quanfu Zhang, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 26, 2011
Early diagnosis of novel SFTS bunyavirus infection by quantitative real-time RT-PCR assayYulan Sun, Mifang Liang, Jing Qu, et al.Journal of Virology|April 12, 2013
Structure of severe fever with thrombocytopenia syndrome virus nucleocapsid protein in complex with suramin reveals therapeutic potentialLianying Jiao, Songying Ouyang, Mifang Liang, et al.Bing Du Xue Bao = Chinese Journal of Virology|July 12, 2016
[Establishment of Quality Control System of Nucleic Acid Detection for Ebola Virus in Sierra Leone-China Friendship Biological Safety Laboratory]Qin Wang, Yong Zhang, Kai Nie, et al.Journal of Molecular Medicine (Berlin, Germany)|February 7, 2012
Structural insights into a human anti-IFN antibody exerting therapeutic potential for systemic lupus erythematosusSongying Ouyang, Bin Gong, Jin-Zhi Li, et al.Virologica Sinica|July 5, 2021
Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 VariantsYuanyuan Qu, Xueyan Zhang, Meiyu Wang, et al.Virologica Sinica|May 8, 2022
Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variantsJia Lu, Qiangling Yin, Rongjuan Pei, et al.Proceedings of the National Academy of Sciences of the United States of America|August 23, 2017
Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitopeYan Wu, Yaohua Zhu, Feng Gao, et al.Emerging Microbes & Infections|November 16, 2023
Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in ChinaYing Liu, Jiayou Zhang, Wen Liu, et al.Pageof 12